Hikma Pharmaceutical reported 279M in EBIT for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
AstraZeneca AZN:LN 3.32B 3.32B
Bayer BAYN:GR 3.47B 2.25B
Fresenius FRE:GR 1.17B 122M
Galapagos GLPG:NA 10.15M 88.35M
Genmab GEN:DC 514M 295M
GRIFOLS GRF:SM 245.2M 40.86M
Hikma Pharmaceutical HIK:LN 279M 1000K
Lonza Group LONN:SW 545M 54M
Orion ORNBV:FH 39.9M 17.4M
Recordati REC:IM 123.05M 3M